Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-02-22
2005-02-22
Lambkin, Deborah C. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S494000
Reexamination Certificate
active
06858643
ABSTRACT:
Crystalline forms of the (3R,5S)- and the (3S,5R)-enantiomers of fluvastatin, referred to as polymorphic Forms A, B1, B2, C, D and E, processes for the preparation of these crystalline forms and pharmaceutical compositions comprising them are disclosed.
REFERENCES:
patent: 4739073 (1988-04-01), Kathawala
patent: 9749681 (1997-12-01), None
O. Tempkin et al., Tetrahedron, vol. 53, No. 31, pp. 10659-10670 (1997).
Burkhard Andreas
Freiermuth Beat
Marcolli Claudia
Szelagiewicz Martin
Van Der Schaaf Paul Adriaan
Ciba Specialty Chemicals Corporation
Lambkin Deborah C.
Mansfield Kevin T.
LandOfFree
Crystalline forms of Fluvastatin sodium does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystalline forms of Fluvastatin sodium, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline forms of Fluvastatin sodium will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3507554